JEFFERSON MOORE: Open Payments
NPI 1104128867 · BATESVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 23 payments from 12 companies in 2025. Trend: 2023 $315 · 2024 $276 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| PFIZER INC. | 1 | $42 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| CVRx, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
Products named: Wegovy, LEQVIO, Kerendia, VYNDAQEL, VERQUVO, INSPIRE, Attruby, Barostim Neo System.
Industry payments across AR — which companies pay providers there.
